Celldex Therapeutics, Inc. (CLDX)
39.30
+0.06
(+0.15%)
USD |
NASDAQ |
Sep 02, 13:58
Celldex Therapeutics Total Assets (Quarterly) : 782.35M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 782.35M |
| March 31, 2026 | 511.25M |
| December 31, 2025 | 582.98M |
| September 30, 2025 | 648.44M |
| June 30, 2025 | 692.41M |
| March 31, 2025 | 739.47M |
| December 31, 2024 | 792.34M |
| September 30, 2024 | 823.18M |
| June 30, 2024 | 845.59M |
| March 31, 2024 | 868.85M |
| December 31, 2023 | 465.63M |
| September 30, 2023 | 280.26M |
| June 30, 2023 | 299.31M |
| March 31, 2023 | 324.52M |
| December 31, 2022 | 352.74M |
| September 30, 2022 | 369.23M |
| June 30, 2022 | 402.96M |
| March 31, 2022 | 424.04M |
| December 31, 2021 | 444.65M |
| September 30, 2021 | 460.20M |
| June 30, 2021 | 204.55M |
| March 31, 2021 | 219.06M |
| December 31, 2020 | 235.84M |
| September 30, 2020 | 255.77M |
| June 30, 2020 | 261.40M |
| Date | Value |
|---|---|
| March 31, 2020 | 112.50M |
| December 31, 2019 | 122.93M |
| September 30, 2019 | 131.84M |
| June 30, 2019 | 142.24M |
| March 31, 2019 | 147.58M |
| December 31, 2018 | 155.81M |
| September 30, 2018 | 168.29M |
| June 30, 2018 | 178.38M |
| March 31, 2018 | 191.38M |
| December 31, 2017 | 315.62M |
| September 30, 2017 | 319.42M |
| June 30, 2017 | 346.07M |
| March 31, 2017 | 360.05M |
| December 31, 2016 | 383.36M |
| September 30, 2016 | 251.95M |
| June 30, 2016 | 271.21M |
| March 31, 2016 | 301.93M |
| December 31, 2015 | 337.58M |
| September 30, 2015 | 352.63M |
| June 30, 2015 | 383.22M |
| March 31, 2015 | 407.70M |
| December 31, 2014 | 248.01M |
| September 30, 2014 | 271.66M |
| June 30, 2014 | 297.59M |
| March 31, 2014 | 318.70M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 49.36B |
| Ionis Pharmaceuticals, Inc. | 2.995B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 67.78M |
| Shareholders Equity (Quarterly) | 714.56M |
| Debt to Equity Ratio | 0.0069 |
| Current Ratio | 11.82 |
| Net Debt Paydown Yield | -0.01% |